November 17-18, 2014 London, UK
May 4 – 9, 2014 Quebec City, Canada
May 5 – 9, 2014 Boston, USA
March 10 – 12, 2014 Turin (Italy)
June 23 – 26, 2014 San Diego, CA
Leiden, the Netherlands, 23 January 2014 – ProteoNic BV, a leading provider of technology for recombinant protein production, will participate in an international consortium that has been awarded a EUR 7 million Framework Program 7 (FP7) Research Grant by the European Commission. The FP7 grant will support the development of novel enzymes for efficient production of antioxidants.
ProteoNic, the experts in vector design and protein production, presented an update on its recently launched 2G UNic™ (second generation) technology for improved biopharmaceutical recombinant protein production on 4 November 2013 at the Cell Culture & Bioprocessing Congress in London.
ProteoNic will present on monday November 4th: Novel UNic™ Vectors and Plug-in Elements for Increased Recombinant Protein Production